Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1QPR

QUINOLINATE PHOSPHORIBOSYLTRANSFERASE (QAPRTASE) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH PHTHALATE AND PRPCP

Summary for 1QPR
Entry DOI10.2210/pdb1qpr/pdb
DescriptorQUINOLINIC ACID PHOSPHORIBOSYLTRANSFERASE, MANGANESE (II) ION, PHTHALIC ACID, ... (5 entities in total)
Functional Keywordsprtase, de novo nad biosynthesis, prpp, transferase, phosphoribosyltransferase, quinolinic acid, structural genomics, psi, protein structure initiative, tb structural genomics consortium, tbsgc
Biological sourceMycobacterium tuberculosis H37Rv
Total number of polymer chains6
Total formula weight183089.80
Authors
Sharma, V.,Grubmeyer, C.,Sacchettini, J.C.,TB Structural Genomics Consortium (TBSGC) (deposition date: 1998-10-17, release date: 1998-10-21, Last modification date: 2024-02-14)
Primary citationSharma, V.,Grubmeyer, C.,Sacchettini, J.C.
Crystal structure of quinolinic acid phosphoribosyltransferase from Mycobacterium tuberculosis: a potential TB drug target.
Structure, 6:1587-1599, 1998
Cited by
PubMed Abstract: . Mycobacterium tuberculosis is the single most deadly human pathogen and is responsible for nearly three million deaths every year. Recent elucidation of the mode of action of isoniazid, a frontline antimycobacterial drug, suggests that NAD metabolism is extremely critical for this microorganism. M. tuberculosis depends solely on the de novo pathway to meet its NAD demand. Quinolinic acid phosphoribosyltransferase (QAPRTase), a key enzyme in the de novo biosynthesis of NAD, provides an attractive target for designing novel antitubercular drugs.
PubMed: 9862811
DOI: 10.1016/S0969-2126(98)00156-7
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.45 Å)
Structure validation

238268

数据于2025-07-02公开中

PDB statisticsPDBj update infoContact PDBjnumon